More articles from Perspective

Open Access
Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life
Yingni Zhang, Chunxian Ou and Cheng Xu

Cancer Biology & Medicine August 2026, 20260316; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0316
Open Access
The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer
Ruoqing Wang, Shuhao Jiang, Qun Zhang and Junjie Li

Cancer Biology & Medicine July 2026, 20260277; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0277
Open Access
Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives
Jing Yu, Maochen Li, Yuhan Zhu, Shengnan Wang, Yuzhao Jiang, Wei Cui and Lingying Wu

Cancer Biology & Medicine June 2026, 23 (6) 788-795; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0102
Open Access
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies
Bohao Zheng, Dian Fan and Shengtao Zhou

Cancer Biology & Medicine June 2026, 20260139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0139
Open Access
Protocol and statistical designs in classic clinical research—toripalimab series trial analysis
Yingjian He, Li Bian and Zefei Jiang

Cancer Biology & Medicine March 2026, 23 (3) 338-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0759
Open Access
Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers
Juanjuan Feng, Xuanzheng Xiao, Zhengke Lian, Ao Zhang and Xiufeng Pang

Cancer Biology & Medicine February 2026, 23 (2) 162-168; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0612
Open Access
Beyond origin: multimodal AI synthesis to resolve cancers of unknown primary
Hongru Shen and Xiangchun Li

Cancer Biology & Medicine January 2026, 23 (1) 21-29; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0636
Open Access
Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units
Jun He and Xinbing Sui

Cancer Biology & Medicine January 2026, 23 (1) 15-20; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0641
Open Access
From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity
Tao Shi, Yiran Cai, Hanbing Wang and Jia Wei

Cancer Biology & Medicine December 2025, 22 (12) 1431-1438; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0547
Open Access
Immunological and metabolic optimization of tumor neoantigen vaccines
Xiafeng Wang, Zhangping Huang, Lin Peng, Shuoxi Xu, Jianfeng Huang and Ji Wang

Cancer Biology & Medicine November 2025, 22 (11) 1275-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0445

Main menu

User menu

Search

More articles from Perspective

Pages

Navigate

More Information

For Authors

Journal Services